The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

Autor: Westphalen, C.B., Martins-Branco, D., Beal, J.R., Cardone, C., Coleman, N., Schram, A.M., Halabi, S., Michiels, S., Yap, C., André, F., Bibeau, F., Curigliano, G., Garralda, E., Kummar, S., Kurzrock, R., Limaye, S., Loges, S., Marabelle, A., Marchió, C., Mateo, J., Rodon, J., Spanic, T., Pentheroudakis, G., Subbiah, V.
Zdroj: In Annals of Oncology November 2024 35(11):936-953
Databáze: ScienceDirect